| Breakdown | TTM | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 9.39M | 6.07M | 9.80M | 6.37M | 4.64M | 4.63M |
| Gross Profit | 4.87M | 4.64M | 5.85M | -1.44M | -508.10K | 1.36M |
| EBITDA | -9.03M | -6.29M | 263.85K | -3.77M | -5.79M | -1.53M |
| Net Income | -9.48M | -4.76M | -4.26M | -8.24M | -9.45M | -2.99M |
Balance Sheet | ||||||
| Total Assets | 40.76M | 16.79M | 16.62M | 24.88M | 26.89M | 30.29M |
| Cash, Cash Equivalents and Short-Term Investments | 6.49M | 3.15M | 2.92M | 3.25M | 6.52M | 12.74M |
| Total Debt | 2.50M | 2.17M | 1.17M | 780.36K | 985.76K | 1.08M |
| Total Liabilities | 15.84M | 11.39M | 7.17M | 11.44M | 7.69M | 10.65M |
| Stockholders Equity | 24.92M | 5.40M | 9.44M | 13.44M | 19.20M | 19.65M |
Cash Flow | ||||||
| Free Cash Flow | -5.34M | 2.92M | -1.10M | -5.07M | -10.60M | -568.46K |
| Operating Cash Flow | -5.30M | 2.96M | 1.64M | -4.96M | -10.57M | -464.68K |
| Investing Cash Flow | -18.51M | -3.49M | -2.74M | -40.08K | -1.78M | 227.28K |
| Financing Cash Flow | 27.97M | 766.48K | 773.36K | 1.73M | 6.14M | 10.56M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
46 Neutral | AU$8.11M | -0.79 | -133.07% | ― | -4.90% | -52.78% | |
43 Neutral | AU$23.11M | -9.91 | ― | ― | 7.32% | 67.11% | |
43 Neutral | AU$7.60M | ― | ― | ― | -26.58% | ― | |
43 Neutral | AU$77.79M | -8.00 | ― | ― | ― | ― | |
42 Neutral | AU$42.50M | -3.68 | -64.13% | ― | -38.03% | -11.27% | |
38 Underperform | AU$18.08M | -4.42 | -135.50% | ― | -48.98% | -12.82% |
archTIS Limited has released a market update presentation outlining information about the company for investors and stakeholders, while stressing that the material is for informational purposes only. The company emphasises that the presentation is not an offer or recommendation to buy its securities and that any investment decisions must be made under applicable securities laws and with appropriate independent advice.
The release underscores that the presentation may contain forward-looking statements subject to significant business and market risks, and that actual outcomes could differ materially from expectations. archTIS also disclaims any warranties regarding the completeness or accuracy of the information provided and limits liability for losses arising from the use of the presentation, highlighting a cautious and risk-aware communication stance toward the market.
The most recent analyst rating on (AU:AR9) stock is a Hold with a A$0.08 price target. To see the full list of analyst forecasts on archTIS Ltd. stock, see the AU:AR9 Stock Forecast page.
archTIS Limited reported a sharp increase in revenue for the half year ended 31 December 2025, with sales from ordinary activities up 120% to $6.1 million compared with the prior corresponding period. Despite this top-line growth, the company recorded a loss of $7.2 million attributable to shareholders, representing a 191% increase in losses year on year, while net tangible assets per share remained negative at $0.011 and no interim dividend was declared.
The results highlight a business that is rapidly scaling revenue in its secure information management niche but still investing heavily and operating at a deeper loss, implying continued pressure on profitability and returns to shareholders in the near term. With no changes in control of subsidiaries during the half and the accounts reviewed by auditors, the update underscores both the company’s growth trajectory and the financial risks stakeholders must weigh as archTIS pursues expansion.
The most recent analyst rating on (AU:AR9) stock is a Hold with a A$0.08 price target. To see the full list of analyst forecasts on archTIS Ltd. stock, see the AU:AR9 Stock Forecast page.
archTIS Limited has secured a contract with a U.S. and European military alliance to deploy its NC Protect software for secure collaboration across transatlantic allied defence operations. The deal, covering more than 2,500 users, has an initial value of about A$416,000 with two option years that could take the total to roughly A$1.22 million, and positions NC Protect as a core access-control layer across multiple civil-military security domains.
The company also reported continued progress on a key U.S. Department of Defense deployment of NC Protect in support of the Pentagon’s Zero Trust security mandate, bolstering its credentials in priority allied defence markets. In parallel, archTIS expanded its financing facilities with Commonwealth Bank of Australia from $2 million to $8 million to strengthen working capital and fund product investment and contract execution, underscoring lender confidence in its growth strategy.
The most recent analyst rating on (AU:AR9) stock is a Hold with a A$0.08 price target. To see the full list of analyst forecasts on archTIS Ltd. stock, see the AU:AR9 Stock Forecast page.
archTIS Ltd. has notified the ASX of the cessation of two tranches of options, AR9AU and AR9AW, after the conditional rights attached to these securities lapsed on 14 January 2026. The options, expiring in March 2026 and December 2026 with exercise prices of $0.1428 and $0.0792 respectively, have become incapable of being satisfied, resulting in a reduction of 340,345 potential securities from the company’s capital structure.
The announcement clarifies that these instruments no longer form part of archTIS’s issued or potentially dilutive capital, tightening the company’s option overhang. This change may modestly affect future dilution calculations for existing shareholders and provides updated transparency on the company’s outstanding equity-linked instruments as at the date of the announcement.
The most recent analyst rating on (AU:AR9) stock is a Hold with a A$0.08 price target. To see the full list of analyst forecasts on archTIS Ltd. stock, see the AU:AR9 Stock Forecast page.
archTIS Ltd. has notified the market of the issue of several tranches of unquoted equity securities under its employee incentive scheme, all of which are not intended to be quoted on the ASX. The company will issue a total of 4,847,024 AR9PR18 restricted stock units expiring 30 June 2028, 3,959,983 AR9PR19 restricted stock units expiring 25 February 2028, and 4,033,598 AR9PR20 performance rights expiring 25 February 2028, potentially increasing staff equity participation and aligning employee incentives with long‑term shareholder value.
The securities were all issued on 25 February 2026 and carry nil exercise price, reflecting their role as remuneration or incentive instruments rather than capital-raising tools. This move underscores archTIS’s ongoing use of equity-based compensation to attract and retain talent, while modestly diluting existing shareholders in exchange for greater alignment between employee and investor interests.
The most recent analyst rating on (AU:AR9) stock is a Hold with a A$0.08 price target. To see the full list of analyst forecasts on archTIS Ltd. stock, see the AU:AR9 Stock Forecast page.
archTIS Limited has scheduled an investor webinar to provide an update on its FY26 first-half performance for the period ended 31 December 2025 and to brief shareholders on current market activities. The online event, to be hosted via Zoom by CEO and Managing Director Daniel Lai and Chief Strategy Officer and U.S. President Kurt Mueffelmann, will be held on 27 February 2026, with investors able to register in advance and participate in a Q&A session.
The webinar underscores archTIS’s efforts to engage more closely with investors and improve transparency around its operational progress and market positioning in the data-centric security sector. By outlining financial performance and market activity in a live, interactive format, the company aims to reinforce stakeholder confidence and highlight how its secure collaboration software is tracking in key government, defence and regulated industry markets.
The most recent analyst rating on (AU:AR9) stock is a Hold with a A$0.08 price target. To see the full list of analyst forecasts on archTIS Ltd. stock, see the AU:AR9 Stock Forecast page.
archTIS Limited has released its Q2 FY26 December 2025 quarterly report presentation, outlining information on its operations and performance for the period. The document is presented strictly for informational purposes, with the company emphasizing that it does not constitute financial advice, an offer of securities, or a basis for investment decisions, and highlighting the inherent risks and uncertainties in forward-looking statements related to its data-centric cyber security business.
The most recent analyst rating on (AU:AR9) stock is a Sell with a A$0.11 price target. To see the full list of analyst forecasts on archTIS Ltd. stock, see the AU:AR9 Stock Forecast page.
archTIS reported a strong December 2025 quarter marked by accelerating traction in the U.S. defence sector, highlighted by the successful deployment of its NC Protect platform into a live Microsoft DoD365 production environment and the renewal of 1,000 production licences with the U.S. Department of Defense, as well as ongoing contracted development work to enhance mission-critical features. The completion and integration of the Spirion acquisition drove Annual Recurring Revenue to $16.3 million, a 308% year-on-year increase, boosted quarterly revenue to $4.6 million with a higher 76% gross margin, and enabled a global cost realignment expected to deliver about A$4.5 million in annualised savings, even as operating expenses and negative operating cash flow rose temporarily due to U.S. expansion and integration costs; together with a signed term sheet for an A$8 million senior secured debt facility, these moves underpin archTIS’s strategic U.S. expansion and reinforce its positioning as a key player in zero trust and data-centric security for defence and regulated markets.
The most recent analyst rating on (AU:AR9) stock is a Sell with a A$0.11 price target. To see the full list of analyst forecasts on archTIS Ltd. stock, see the AU:AR9 Stock Forecast page.
archTIS Limited has applied to the Australian Securities Exchange (ASX) for quotation of an additional 65,728 fully paid ordinary shares under its existing AR9 ticker. The new shares, issued on 28 January 2026 following the exercise or conversion of existing options or other convertible securities, modestly increase the company’s quoted capital base and may slightly enhance liquidity for investors, although the quantum is not large enough to materially alter the company’s overall capital structure.
The most recent analyst rating on (AU:AR9) stock is a Sell with a A$0.11 price target. To see the full list of analyst forecasts on archTIS Ltd. stock, see the AU:AR9 Stock Forecast page.
archTIS Limited has scheduled an investor webinar via Zoom for Friday, 30 January 2026 to provide a company update and discuss its Quarterly Activities Report and Appendix 4C for the second quarter of FY2026, covering the period ended 31 December 2025. The session, to be led by CEO and Managing Director Daniel Lai and Chief Strategy Officer and U.S. President Kurt Mueffelmann, will outline recent operational and financial performance and what lies ahead for the remainder of FY2026, with a brief Q&A segment allowing shareholders and potential investors to engage directly with management. The announcement underscores the company’s efforts to maintain transparent communication with the market and support investor engagement through its dedicated online Investor Centre, where governance materials, reports and other company information are made available.
The most recent analyst rating on (AU:AR9) stock is a Sell with a A$0.11 price target. To see the full list of analyst forecasts on archTIS Ltd. stock, see the AU:AR9 Stock Forecast page.
archTIS Limited has completed the custom software development work for its U.S. Department of Defense project announced in October 2025, delivering mission-specific capability enhancements that are now production-ready. With only a third-party integration component remaining, expected to be finalised by early February, the milestone underpins continued engagement with the U.S. DoD and supports the company’s push toward expanded deployment in secure Microsoft DoD365 environments and a potential larger-scale enterprise licensing arrangement, strengthening its positioning in defence-focused data security and opening doors to similar opportunities with coalition partners and allied nations.
The most recent analyst rating on (AU:AR9) stock is a Sell with a A$0.11 price target. To see the full list of analyst forecasts on archTIS Ltd. stock, see the AU:AR9 Stock Forecast page.
archTIS Limited has announced a change in the shareholdings of Managing Director Daniel Lai following the lapse and vesting of performance rights. On 22 December 2025, 1,666,016 AR9PR10 performance rights held by Lai lapsed, while 208,252 AR9PR10 performance rights vested into an equivalent number of fully paid ordinary shares at no consideration, increasing his direct shareholding to 10,737,686 shares. His holdings in various series of unlisted options and remaining performance rights are unchanged, and the company confirmed there were no trades during a closed period, indicating the changes stem purely from the operation of the company’s long-term incentive arrangements rather than market transactions.
The most recent analyst rating on (AU:AR9) stock is a Hold with a A$0.10 price target. To see the full list of analyst forecasts on archTIS Ltd. stock, see the AU:AR9 Stock Forecast page.
archTIS Limited has issued fully paid ordinary shares and notified the market that these securities were issued without a disclosure document under the relevant provisions of the Corporations Act. The company confirmed it is up to date with its financial reporting and continuous disclosure obligations and stated there is no excluded information that investors would reasonably expect to find in a formal disclosure document, signalling that the new share issuance is compliant with Australian regulatory requirements and does not introduce undisclosed risks for shareholders.
The most recent analyst rating on (AU:AR9) stock is a Hold with a A$0.10 price target. To see the full list of analyst forecasts on archTIS Ltd. stock, see the AU:AR9 Stock Forecast page.
ArchTIS Ltd has notified the market that several classes of equity incentives, including performance rights, options and restricted stock units, have lapsed because the conditions attached to them were not met or are no longer capable of being satisfied. The cessation affects a total of more than 7.6 million securities as of 22 December 2025, signalling a reduction in potential future equity dilution for existing shareholders and updating the company’s issued capital structure in line with ASX disclosure requirements.
The most recent analyst rating on (AU:AR9) stock is a Hold with a A$0.10 price target. To see the full list of analyst forecasts on archTIS Ltd. stock, see the AU:AR9 Stock Forecast page.
archTIS Ltd has applied to the ASX for quotation of 6,160,191 new fully paid ordinary shares, trading under the ticker AR9. The newly issued securities, dated 22 December 2025, expand the company’s quoted share capital base, potentially enhancing liquidity for investors and signalling additional capital or option conversions that may support its ongoing corporate and operational activities.
The most recent analyst rating on (AU:AR9) stock is a Hold with a A$0.10 price target. To see the full list of analyst forecasts on archTIS Ltd. stock, see the AU:AR9 Stock Forecast page.
archTIS has advanced its U.S. Department of Defense opportunity by deploying its NC Protect software into the DoD’s Microsoft DoD365 production environment and securing a renewal of 1,000 licenses for active mission operations, signalling a shift from pilot projects to sustained operational use within the warfighter network. The company is also delivering customised software enhancements requested by the DoD to enable greater interoperability and scale, while enterprise licence negotiations have resumed following the U.S. government shutdown, with the potential for large, multi-thousand-user deployments that could position NC Protect as a key tool in meeting the Pentagon’s Zero Trust security mandates. In parallel, archTIS is progressing its integration of recently acquired Spirion, realising A$4.5 million in annual cost synergies and launching cross-sell campaigns in the U.S., supported by a new non-dilutive A$8 million drawdown debt facility aimed at accelerating its penetration of the U.S. market and strengthening its competitive position in data security.
The most recent analyst rating on (AU:AR9) stock is a Hold with a A$0.10 price target. To see the full list of analyst forecasts on archTIS Ltd. stock, see the AU:AR9 Stock Forecast page.
archTIS Ltd. has notified the market that 8,642,851 options (AR9AS), each exercisable at A$0.20 and expiring on 13 December 2025, have lapsed unexercised, resulting in the cessation of these securities. The expiry reduces the company’s pool of potential dilution from convertible securities but does not affect the current issued share capital, and may be interpreted by investors as a normal clean-up of its capital structure rather than a direct signal on underlying operations.
The most recent analyst rating on (AU:AR9) stock is a Hold with a A$0.10 price target. To see the full list of analyst forecasts on archTIS Ltd. stock, see the AU:AR9 Stock Forecast page.
archTIS Limited has disclosed changes to the securities held by Managing Director Daniel Lai, detailing an update to his equity-based remuneration package.
The company reported that Lai has been granted 169,394 new unlisted options expiring in December 2029 and 846,966 new performance rights as director incentives, while an earlier tranche of 119,047 unlisted options expiring in December 2025 has lapsed. Following these adjustments, his holding remains a substantial mix of fully paid ordinary shares, multiple series of unlisted options with varying strike prices and maturities, and performance rights, signalling a continued emphasis on long-term, equity-linked incentives to align executive interests with shareholder value.
The most recent analyst rating on (AU:AR9) stock is a Hold with a A$0.10 price target. To see the full list of analyst forecasts on archTIS Ltd. stock, see the AU:AR9 Stock Forecast page.
archTIS Ltd. has announced the issuance of unquoted equity securities, including 169,394 unlisted options and 846,966 performance rights, as part of an employee incentive scheme. This move is aimed at enhancing employee engagement and aligning their interests with the company’s long-term goals, potentially impacting the company’s operational dynamics and market positioning.
The most recent analyst rating on (AU:AR9) stock is a Hold with a A$0.10 price target. To see the full list of analyst forecasts on archTIS Ltd. stock, see the AU:AR9 Stock Forecast page.
archTIS Limited announced the resignation of Mrs. Erlyn Dawson from her role as Joint Company Secretary, effective immediately. The company expressed gratitude for her contributions and confirmed that Mr. Winton Willesee and Mr. Andrew Burns will continue as Joint Company Secretaries, ensuring continuity in communications with the ASX. This change in company secretarial roles is not expected to impact the company’s operations significantly, as the remaining secretaries will maintain compliance with ASX Listing Rule matters.
The most recent analyst rating on (AU:AR9) stock is a Hold with a A$0.10 price target. To see the full list of analyst forecasts on archTIS Ltd. stock, see the AU:AR9 Stock Forecast page.
archTIS Ltd. announced a change in the director’s interest as Dr. Marcus Thompson acquired 3,412,969 unlisted options as part of his remuneration package. This issuance of Director Incentive Options, approved at the 2025 Annual General Meeting, reflects the company’s commitment to aligning executive compensation with shareholder interests and could impact the company’s governance and strategic direction.
The most recent analyst rating on (AU:AR9) stock is a Hold with a A$0.10 price target. To see the full list of analyst forecasts on archTIS Ltd. stock, see the AU:AR9 Stock Forecast page.
archTIS Ltd. announced the issuance of 3,412,969 unquoted options set to expire on November 22, 2027, with an exercise price of $0.0972. This issuance, part of a previously announced transaction, reflects the company’s strategic financial maneuvers to enhance its capital structure, potentially impacting its market positioning and stakeholder interests.
The most recent analyst rating on (AU:AR9) stock is a Hold with a A$0.10 price target. To see the full list of analyst forecasts on archTIS Ltd. stock, see the AU:AR9 Stock Forecast page.